Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mo | BGM Group Ltd. - 20-F, Annual and transition report of foreign private issuers | - | SEC Filings | ||
07.01. | BGM Group Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
29.11.24 | AIX Inc.: AIX and BGM Group Forge Strategic Deal, Leading Healthcare, Pharma, and Insurance Industry Expansion with AI | 228 | GlobeNewswire (Europe) | GUANGZHOU, China, Nov. 29, 2024 (GLOBE NEWSWIRE) -- AIX Inc. (Nasdaq: AIFU) (the "Company" or "AIX"), a leading independent technology-driven financial services provider in China, today announced... ► Artikel lesen | |
BGM GROUP Aktie jetzt für 0€ handeln | |||||
27.11.24 | BGM Group Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
29.10.24 | Qilian International Holding Group Limited Announces Name Change to BGM Group Ltd. | 162 | PR Newswire | CHENGDU, China, Oct. 29, 2024 /PRNewswire/ -- Qilian International Holding Group Ltd. ("Qilian" or the "Company") (NASDAQ: BGM) is pleased to announce that effective... ► Artikel lesen | |
22.10.24 | Qilian International Holding Group - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
09.09.24 | Qilian International Holding Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
13.08.24 | Qilian International Holding Group Limited: Qilian International Holding Group Ltd. Announces Trading Ticker Symbol to "BGM" | 128 | PR Newswire | CHENGDU, China, Aug. 13, 2024 /PRNewswire/ -- Qilian International Holding Group Ltd. ("Qilian" or the "Company") (NASDAQ: QLI), a China -based pharmaceutical and chemical products manufacturer... ► Artikel lesen | |
12.07.24 | Qilian International Holding Group Limited: Qilian International Holding Group Ltd Regained Compliance with Nasdaq's Minimum Bid Price Rule | 192 | PR Newswire | CHENGDU, China, July 12, 2024 /PRNewswire/ -- Qilian International Holding Group Limited (NASDAQ: QLI) ("Qilian" or the "Company"), a China -based pharmaceutical and chemical products manufacturer... ► Artikel lesen | |
18.06.24 | Qilian International Holding Group Limited Announces 1 for 5 Reverse Share Split | 205 | PR Newswire | CHENGDU, China, June 18, 2024 /PRNewswire/ -- Qilian International Holding Group Limited (NASDAQ:QLI) ("Qilian" or the "Company"), a China -based pharmaceutical and chemical products manufacturer... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BAYER | 21,495 | +0,23 % | Nach 20-Jahres-Tief: Bayer: Aktie zweistellig im Plus seit Jahresbeginn - ist das der Turnaround? | © Foto: Juan Vega - EUROPA PRESSBayers Pharmasparte kämpft mit Umsatzrückgängen, doch Analysten sehen ab 2027 Wachstumspotenzial. Neue Medikamente und Strategien sollen die Patentklippe von Xarelto... ► Artikel lesen | |
GILEAD SCIENCES | 89,96 | -1,04 % | Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years | ||
AURORA CANNABIS | 3,568 | +0,45 % | Aurora Cannabis Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
ABBVIE | 167,88 | -0,58 % | AbbVie To Collaborate With Neomorph To Develop Molecular Glue Degraders For Oncology And Immunology | WASHINGTON (dpa-AFX) - AbbVie, Inc. (ABBV) and Neomorph, Inc. announced Thursday a collaboration and option-to-license agreement to develop novel molecular glue degraders for multiple targets... ► Artikel lesen | |
CANOPY GROWTH | 1,982 | -0,20 % | Trump jetzt am Drücker: Neue Hoffnungen für Tilray, Canopy & Co. oder droht der nächste Abverkauf? | © Foto: adobe.stock.comDer Amtsantritt Donald Trumps am gestrigen Montag schlug hohe Wellen. Seine Antrittsrede machte deutlich, dass sich Vieles ändern wird. Auch für den Cannabis-Sektor dürften es... ► Artikel lesen | |
ASTRAZENECA | 133,55 | +0,23 % | GOLDMAN SACHS stuft ASTRAZENECA auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für Astrazeneca mit einem Kursziel von 15558 Pence auf "Buy" belassen. Die US-Zulassung für Datroway gegen bestimmte... ► Artikel lesen | |
TILRAY BRANDS | 1,042 | -0,19 % | Tilray Brands, Inc.: Get Ready for the Ultimate Game Day with Tilray Brands: Nationwide Brewery Events! | ||
BRISTOL-MYERS SQUIBB | 56,31 | -2,56 % | Biotechnologie: Weltweiter Markt für Zelltherapie soll bis 2034 jährlich um 20% wachsen | ||
TEVA | 20,500 | -1,44 % | Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi and Simponi Aria (golimumab) | REYKJAVIK, Iceland and PARSIPPANY, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for... ► Artikel lesen | |
TAAT GLOBAL ALTERNATIVES | 0,135 | 0,00 % | TAAT Global Alternatives confirms deal to acquire Premium Products LLC | ||
MPH HEALTH CARE | 24,000 | +1,69 % | Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH): Kaufen / Kursziel: EUR 108 | Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH 18.12.2024 / 15:36 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group. The issuer... ► Artikel lesen | |
CRONOS GROUP | 1,794 | -0,22 % | Cronos-Aktie erreicht 52-Wochen-Tief bei 1,86 US-Dollar | ||
DIGICANN VENTURES | 0,004 | 0,00 % | CSE Bulletin: Halted for Fundamental Change - Digicann Ventures Inc. (DCNN) | le 30 septembre/September 2024
Trading in the shares of Digicann Ventures Inc. will remain halted pending receipt and review of acceptable documentation regarding the Fundamental Change pursuant... ► Artikel lesen | |
CRESCO LABS | 0,831 | -2,58 % | Cresco Labs Demonstrates Success of Cash Flow Focused Strategy with Third Quarter 2024 Financial Results | Record quarterly operating cash flow of $49 million and year to date operating cashflow of $103 million, an increase of 66% from the prior year period
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF)... ► Artikel lesen | |
GREEN THUMB INDUSTRIES | 6,660 | -1,62 % | Green Thumb Industries Inc. to Hold Fourth Quarter and Full Year 2024 Earnings Conference Call on February 26, 2025 |